Dr. Lal PathLabs’ wholly owned subsidiary — Pathlabs Unifiers has received approval for signing binding term sheet for acquisition of 70% equity stake in a ‘New Company to be incorporated’. The Board of Director of Pathlabs Unifiers at their meeting held on October 01, 2019, approved the same.According to the Term Sheet, the ‘New Company to be incorporated’ will house the business of Amins Pathology Referral Laboratory, a Proprietorship concern of Dr. Ripal Padmani and engaged in Pathology Business in Vadodara in Gujarat, before Pathlabs Unifiers buys 70% stake in it.
Dr. Lal Pathlabs is recognized as a centre of innovation and a premier clinical pathology laboratory. It is the largest and most respected diagnostic service provider in the country.